glucosidase inhibitors

glu·co·si·dase in·hib·i·tors

agents (for example, acarbose) that reduce gastrointestinal absorption of carbohydrates. This group of drugs has been known popularly as "starch blockers." They lower plasma glucose levels and tend to cause weight loss. A limiting side-effect is flatulence.

glu·co·si·dase in·hib·i·tors

(glū-kō'sid'ās in-hib'i-tŏrz)
Agents such as acarbose that reduce gastrointestinal absorption of carbohydrates. This group of drugs, known popularly as "starch blockers," lowers plasma glucose levels and tend to cause weight loss. Flatulence is a limiting side-effect.

glucosidase inhibitors

Drugs, such as acarbose (Glucobay), that interfere with the absorption of carbohydrates and are used as aids to weight loss. Acarbose is used to treat Type 2 diabetes that is inadequately controlled by diet and oral hypoglycaemics.

glu·co·si·dase in·hib·i·tors

(glū-kō'sid'ās in-hib'i-tŏrz)
Agents that reduce gastrointestinal absorption of carbohydrates; known popularly as "starch blockers." They lower plasma glucose levels and tend to cause weight loss but cause flatulence.
References in periodicals archive ?
Recently, some new approaches for controlling the pH, including a-amylase, glucosidase inhibitors and organic acid, have been explored (McLaughlin et al.
Acarbose is a [alpha]-amylase and glucosidase inhibitor that is indicated for the control of blood glucose in diabetic patients.
The prescribed alpha glucosidase inhibitors were- voglibose 0.
However pioglitazone combination therapy with metformin and alpha glucosidase inhibitors (regimen C and D) revealed lower weight and BMI gain: 0.
The glucosidase inhibitors are designed to inhibit the amylase enzymes produced by the pancreas which are essential to the digestion of carbohydrates.
Nutrients that may slow carbohydrate absorption include white kidney bean (amylase inhibitor), (44-47) InSea[TM] (containing amylase and glucosidase inhibitors from special seaweeds), (48-51) Irvingia (amylase inhibitor) (52-55) and L-arabinose (sucrase inhibitor).
In addition, Glucosidase inhibitors have therapeutic potential in the treatment of disorders such as human immunodeficiency virus (HIV) infection, metastatic cancer, and lysosomal storage diseases (Melo et al.
Glucosidase inhibitors such as deoxynojirimycin (DNM) are reported to be potent antivirals and have been used in the treatment of an HIV infected lymphocyte culture, in which they inhibited the spread of the virus (Papandreou et al.
56 (Avandia) once or divided (4 mg) GLUCOSIDASE INHIBITORS acarbose 25-100 mg $1.
Injectables Market: (Insulin, exenatide) - Oral Drugs Market: (Metformin, sulfonylureas, thaizolidinediones, dipeptidyl inhibitors, meglitinides, alpha glucosidase inhibitors, combination medications)
Surveyed physicians indicated a strong preference for metformin as first-line treatment and sulfonylureas and alpha glucosidase inhibitors as second-line treatments.